Expand BDTX Menu
BDTX MENU

BDTX Stock Posts


Unusual Option Volume

BDTX Black Diamond Therapeutics2.96-0.59 (-16.6%)

Black Diamond Therapeutics trades 5,210 contracts. The highest volume is in the 18-Jun-26 2.5 calls. News: Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
View Details...
Unusual Option Volume

BDTX Black Diamond Therapeutics3.57+0.57 (+19.0%)

Black Diamond Therapeutics trades 2,411 contracts. The company has the following event: Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC on May 21, 2026.
View Details...
Unusual Option Volume

BDTX Black Diamond Therapeutics2.63-0.82 (-23.8%)

Black Diamond Therapeutics trades 2,296 contracts. The company has the following event: Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update on Dec 3, 2025. News: Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM
View Details...
Unusual Option Volume

BDTX Black Diamond Therapeutics1.90+0.18 (+10.5%)

Black Diamond Therapeutics trades 2,232 contracts.
View Details...
Unusual Option Volume

BDTX Black Diamond Therapeutics2.25+0.57 (+33.9%)

Black Diamond Therapeutics trades 2,382 contracts. News: Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
View Details...
Unusual Option Volume

BDTX Black Diamond Therapeutics5.16+0.40 (+8.4%)

Black Diamond Therapeutics trades 4,249 contracts. The company has the following event: Investor Webcast Presentation on Sep 23, 2024. News: Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes